3-Chloro-5-(2-fluoroethoxy)pyridazine

Catalog No.: 
ACMZDC724
CAS No.: 
1346691-39-1
Molecular Formula: 
C6H6ClFN2O
Molecular Weight: 
176.58
3-Chloro-5-(2-fluoroethoxy)pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$96.00InquiryInquiry
1g90%$261.00InquiryInquiry
5g90%$667.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-5-(2-fluoroethoxy)pyridazine
IUPAC Name3-chloro-5-(2-fluoroethoxy)pyridazine
MDL No.MFCD19688855
Molecular FormulaC6H6ClFN2O
Molecular Weight176.58
SMILESFCCOC1=CC(Cl)=NN=C1
InChI KeyHOIPFGFVVVGLQS-UHFFFAOYSA-N
Synonym3-Chloro-5-(2-fluoroethoxy)pyridazine;Pyridazine, 3-chloro-5-(2-fluoroethoxy)-
CAS No.1346691-39-1
PubChem CID71303462

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMZDC724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACENAW254 route compound structure diagram
    ACENAW2541837-55-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMZDC724 route product structure diagram
    ACMZDC7241346691-39-1
Inquiry

2. ACMZDC724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCOTQ063 route compound structure diagram
    ACCOTQ0631415928-75-4In Stock
  4. Then
  5. ACMZDC724 route product structure diagram
    ACMZDC7241346691-39-1
Inquiry

3. ACMZDC724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCOTQ063 route compound structure diagram
    ACCOTQ0631415928-75-4In Stock
  4. Then
  5. ACMZDC724 route product structure diagram
    ACMZDC7241346691-39-1
Inquiry

Comments (0)